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Abstract
Background: The development of ovarian follicles hinges on the timely exposure to the appropriate combination of
hormones. Follicle stimulating hormone (FSH) and luteinizing hormone (LH) are both produced in the pituitary gland
and are transported via the blood circulation to the thecal layer surrounding the follicle. From there both hormones
are transported into the follicle by diffusion. FSH-receptors are expressed mainly in the granulosa while LH-receptors
are expressed in a gradient with highest expression in the theca. How this spatial organization is achieved is not
known. Equally it is not understood whether LH and FSH trigger distinct signalling programs or whether the distinct
spatial localization of their G-protein coupled receptors is sufficient to convey their distinct biological function.
Results: We have developed a data-based computational model of the spatio-temporal signalling processes within
the follicle and (i) predict that FSH and LH form a gradient inside the follicle, (ii) show that the spatial distribution of
FSH- and LH-receptors can arise from the well known regulatory interactions, and (iii) find that the differential activity
of FSH and LH may well result from the distinct spatial localisation of their receptors, even when both receptors
respond with the same intracellular signalling cascade to their ligand.
Conclusion: The model integrates the large amount of published data into a consistent framework that can now be
used to better understand how observed defects translate into failed follicle maturation.
Keywords: Ovarian follicle development, PDE model, Computational biology, Bovine
Background
Ovarian follicular development has been studied for
decades and has allowed major progress in animal breed-
ing and assisted reproduction in the human. Many animal
models of folliculogenesis are in use [1], partly in their
own right to help the advancement of breeding and partly
as models for human reproduction. Because of the bulk of
published data dealing with bovine folliculogenesis and its
great similarity to its human counterpart [2] we focused
here on the bovine as a model system. As humans, horses
and some sheep breeds, the cow is a mono-ovulatory
species [3], i.e. one dominant follicle is selected from a
cohort of 5-30 follicles [2,4]. All other recruited follicles
undergo atresia [5]. The number of early growing folli-
cles slowly declines with increasing age. Key regulators of
follicular selection and maturation are the gonadotropins
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follicle-stimulating hormone (FSH) and luteinizing hor-
mone (LH), both secreted in the pituitary [5]. While the
initial, slow growth of follicles is independent of these
gonadotropins, further progression to the antral follicu-
lar state requires FSH [6]. FSH induces the expression of
a wide range of genes, including those of the LH-receptor
and the aromatase, an enzyme that converts androgens
into estrogens [7]. Within the follicle the regulatory inter-
actions result in a complex network (Figure 1), with many
of the components restricted spatially.
In spite of much detailed data, an integrated under-
standing of the processes regulating folliculogenesis is still
lacking, and given the many incoherent feedbacks, several
experimental findings appear counterintuitive. Theoreti-
cal models bear the potential to integrate large amounts
of information into a consistent framework. A number
of theoretical models have already been developed for
ovarian follicle development (for a review see [8]), but
only few models explore the processes within the follicle.
Given the large size of both human and bovine follicles
© 2013 Iber and De Geyter; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Iber and De Geyter BMC Systems Biology 2013, 7:60 Page 2 of 24
http://www.biomedcentral.com/1752-0509/7/60
Figure 1 Regulation of follicular development. The modelled
signalling network. In brief, FSH- and LH-signalling enables IGF
signalling in several ways (arrow A1), and enhances the production of
androgens (A2), as well as the production and activity of aromatase
(A3), the enzyme that catalyzes androgens into estradiol. IGF
signalling is necessary for the gonadotropin-dependent expression of
aromatase (A4), enhances the production of FSH and LH receptors
(A5, A6), and reduces the expression of estrogen receptors (A7).
Estrogen signalling enhances the production of aromatase (A8), as
well as the production of the receptors for FSH (A9), LH (A10), and
estradiol (A11). FSH receptor expression is observed also in the
absence of FSH, LH, and estrogen signalling, and we therefore
introduce a further regulation-independent component ϑ , which
may represent testosterone-dependent signalling (A12). Blue arrows
indicate exchange with the blood, black arrows indicate chemical
reactions (binding or catalysis), green arrows indicate activating
impacts and red arrows indicate inhibitory impacts. All components
also decay, but for greater clarity decay reactions have not been
included in the scheme. For a detailed description of the network
interactions along with the evidence see the main text.
(15-20 mm), gradients are likely to form, and transport by
diffusion may become limiting as indeed noted in mod-
els of oxygen transport in the follicle [9-11]. Since many of
the signalling components are produced only in isolated
parts of the follicle, with some diffusing and others being
cell-bound, also spatio-temporal signalling gradients can
be expected to emerge that may play an important role
and may explain some of the counterintuitive data.
We therefore sought to build a reaction-diffusion model
that would describe the signalling dynamics of the reg-
ulatory interactions between FSH, LH, estradiol, andro-
gens, and insulin growth factors (IGF) in space and time.
Quantitative data is available to determine virtually all
parameter values, and the model is consistent with pub-
lished data. The data-based model can be used to explore
the patterning mechanisms inside the follicle, and to
understand the molecular causes and effects of alterations
observed in infertile patients.
Methods
Model development
Follicle development in the cow has been described in
great detail [3,12] and much data is available to base
the model on. We will focus on the development of the
dominant follicle and leave the follicle selection process
to future work. We aim at developing a parsimonious
model for the process and thus seek to keep the regulatory
interactions as simple as possible while reproducing the
measurements. We focus on the hormones FSH (F), LH
(L) and their receptors, on androgens (A) estradiol (E) and
the estrogen receptor for steroid-dependent signalling,
as well as on IGF signalling (I). The aromatase is not
explicitly included in this parsimonious model because
its activity can well be approximated as the direct result
of IGF signalling and regulation through FSH and LH as
discussed in detail below. Receptors of FSH, LH, and estra-
diol will be denoted Ri and the receptor complexes Ci,
with i = {F , L,E}. The modelled core network that regu-
lates the development of the follicle is shown in Figure 1.
Before we discuss the regulator interactions in detail we
first introduce the geometry of the computational domain.
In contrast to human follicular development [13,14], the
thickness of the granulosa layer of the bovine follicle has
not yet been measured during its growth. Given the rota-
tional symmetry, the fast mixing in the follicular fluid,
and the lack of more detailed data, we restrict the model
to a 1D cross-section through the follicle as illustrated
in Figure 2A-D. Experimental measurements show that
growth of the dominant follicle is about linear with time
[15,16]. We can therefore approximate the growth process
as a uniform expansion of the domain such that the length
(t) of the domain relates linearly to time, i.e.
(t) = (0) + v × t, (1)
where v is the growth speed of the domain. The domain
is set to x(t) = (t)ξ where ξ denotes the stationary
coordinate frame ξ ∈[−1, 1].
At the beginning of follicular development the oocyte
resides in the center of the follicle, surrounded by gran-
ulosa and theca cells (Figure 2A). At later stages a fluid-
filled antrum emerges and the oocyte is thought to
become located more at the periphery of the antrum of
the follicle (Figure 2C). We will simulate both situations
and discuss the impact of the fluid-filled cavity and the
biased localisation of the oocyte. Certain reactions differ
in the compartments. We therefore need to define com-
partment boundaries in the simulation. The thicknesses
of theca and granulosa have been reported. In the first set
of simulations we will only consider granulosa and theca
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Figure 2 The Geometry of the ovarian Follicle. (A) In the follicle the oocyte is embedded in somatic tissue. The innermost layer are the cumulus
cells (yellow) followed by a layer of granulosa cells (pink), and an outer layer, the theca (brown), that is enervated by blood vessels. Formation of
androgens is restricted to the theca, while the formation of estradiol is restricted to the granulosa cells. (B) The computational domain represents a
1D cross-section of a follicle and expands over time. The outer part of the domain (brown) is the theca, the intermediate layers (pink) represent the
granulosa; cumulus cells and the oocyte are in the center (yellow). (C-D) A more refined computational domain that also includes the follicular fluid
(blue) on one side of the cumulus oocyte complex.
(Figure 2A). Accordingly, we only need to define the posi-
tion of the compartment boundary between granulosa
and theca. The antral bovine follicle expands from a diam-
eter of about 5 mm to about 20 mm [15,16]. The thickness
of the theca interna measures only about 75 μm in the
dominant follicle, and the thickness of the theca remains
constant [17]. The exact thickness of the theca is not rele-
vant to the model because the blood flow determines the
concentration of the soluble factors in this compartment
and their distribution is therefore not diffusion-limited;
the measured serum concentrations were reproduced by
adjustment of the relative gain and loss rates. We can
thenmake the simplifying assumption that the thecal layer
scales over time, such that the border between the granu-
losa and the thecal layer stays at a constant position on the
stationary domain, ξθ = 1 − 2 × 0.1/20 = 0.99. To show
that this assumption is valid we include the plots, which
are shown in Figures 3, 4, 5 and 6, with a 20% thicker the-
cal layer in the Supplementary Material (Additional file 1:
Figure S1, Additional file 2: Figure S2, Additional file 3:
Figure S3 and Additional file 4: Figure S4), using the same
parameter values as before (Table 1). As can be seen, only
the concentration of androgens, which are produced in
the theca, increases significantly as the thickness of the
thecal layer is increased (Additional file 3: Figure S3); the
overall gradient shapes remain very similar (Additional
file 1: Figure S1, Additional file 2: Figure S2, Additional
file 3: Figure S3 and Additional file 4: Figure S4). The
small differences could be removed by adjusting the thecal
production rates accordingly. The spatial restriction of
reactions to theca () or granulosa () (as shown in
Figure 2A,B) can then be incorporated by the use of a
Heaviside function H, i.e.
 = H(ξ2 − ξ2θ )
 = 1 −  (2)
The quadratic term was included to represent the theca
on both the positive and the negative x-axis (x ∈
(t)× [−1, 1]).
When we include the follicular fluid in the simulations,
the left part of the granulosa domain is reduced and follic-
ular fluid is taking the space (Figure 2C). The antral bovine
follicle expands from a diameter of about 5 mm to about
20 mm [15,16]. The thickness of the theca interna mea-
sures about 75 μm [17], and the thickness of the parietal
granulosa is about 50-65 μm in dominant bovine folli-
cles [17,18]. The cumulus oocyte complex (COC) in the
mature, dominant human follicle measures about 3 mm
in diameter. The remaining part is filled by the follicular
fluid. We will not separately consider the granulosa cells
that surround the oocyte as part of the COC, because,
unlike in published research data dealing with human fol-
licle development [19], such a distinction is not made in
published research, on which the bovine model is based
(i.e. [15,16]). The spatial restriction of reactions to theca
(), granulosa () or follicular fluid () (as shown in
Figure 2C,D) can then be incorporated by a combination
of Heaviside functions as
 = H(ξ2 − ξ2θ )
 = H(ξ − ξφ1) − H(ξ − ξφ2)
 = 1 −  − . (3)
As before the theca domain is set to ξθ = 0.99. The
granulosa layer adjacent to the theca is also very thin
compared to the diameter of the follicle (which measures
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Figure 3 Time-dependent expression profiles in the follicle. Simulated and measured expression levels of LH receptor in granulosa and theca,
and of the FSH receptor and the aromatase in the granulosa during the 1st wave of the bovine follicle maturation process. The data was recorded by
[15,16]. The lower curves that extend to 10 days are the measurements in [16]; the follicles in these measurements were growing more slowly than
in the study by [15]. Note that the dominant follicle undergoes atresia from day 6. (A) Data (dotted lines) and simulation predictions (solid line) of LH
receptor expression in the theca. (B) Data (dotted lines) and simulation predictions (solid line) of LH receptor expression in the granulosa. (C) Data
(dotted lines) and simulation predictions (solid line) of FSH receptor expression in the granulosa. (D) Data (dotted lines) and simulation predictions
(solid line) of aromatase expression in the granulosa. The shaded area indicates the standard deviation of the simulations when noise is applied to
the parameter values.
about 20 mm in diameter), and measures about 50-65 μm
in bovine follicles [17,18]. Experiments reveal a broad dis-
tribution of follicular wall thickness in early follicles [18].
As the follicles grow with time, the distribution of fol-
licular wall thickness appears to become more constant
in the dominant follicles [17,18], whereas the thickness
of the regressing follicles decreases [17]. In the absence
of more detailed data on the relative expansion of the
bovine granulosa layer we will assume that this layer scales
with the expanding follicle, i.e. ξφ1 = −ξθ + 0.1/20 =
−0.985. This implies a granulosa thickness of 12.5 μm in
the small 5mm follicles, which is at the lower limit of the
observed distribution of granulosa thickness during early
follicular growth. The COC in pre-ovulatory human fol-
licles, which measure about 20 mm in diameter, is about
3 mm in diameter and is located adjacent to the mural
granulosa. The follicular fluid fills the rest of the domain
such that ξφ2 = −ξφ1 − 3/20 = 0.835. All soluble pro-
teins (but not the receptors) can diffuse into the follicular
fluid. Given the absence of receptors in the follicular fluid,
receptor-dependent degradation does not occur within
the follicular fluid. Moreover, the, in comparison to the
half-life of FSH, much shorter half-life of LH is attributed
to unspecific cellular degradation processes that are trig-
gered by the particular glycosylation of LH. Since cells
are absent from the follicular fluid, we assume that LH is
not degraded in the follicular fluid. Similarly, we assume
that FSH, androgens, and estradiol are not degraded in the
follicular fluid. This assumption is not critical for model
conclusions because the concentrations in the follicular
fluid can be adjusted by altering the production rates.
Since the hormones and their receptors can all diffuse
within the follicle, if at different velocities, we formu-
late the model as isotropic advection-reaction-dispersion
equations for a compound ci with diffusion coefficient Di
and reaction termsR(ci):
∂tci + ∇ (uci) = Di∇2ci +R (ci) (4)
where u denotes the external velocity field. Since we
assume uniform growth on a 1D spatial domain we can
solve a reformulated set of equations on a static domain
ξ = [−1, 1] with x = (t)ξ :
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Figure 4 FSH and LH gradient formation in the follicle. At time zero no hormones are present in the follicle (black line). Over the next five days
LH and FSH diffuse into the follicular domain from the boundary (theca) and form a gradient. The five time points are equally spaced at 0 (black),
1 (cyan), 2 (blue), 3 (green), 4 (yellow), and 5 days (red) curves. Panels A and B show the profiles on the growing domain. Panels C and D show the
concentration profiles on a scaled domain. Panels E and F show the concentration profiles on a scaled domain if we include the fluid-filled antrum
on one site of the COC block. Panels G and H show the concentration profiles on a scaled domain if we assume rapid mixing in the fluid-filled
antrum. The shading indicates the different parts of the follicle, i.e. theca (white), granulosa cells (dark grey), cumulus cells (light grey), and follicular
fluid (blue). Note that the theca and granulosa layers are very thin and thus barely visible.
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Figure 5 The production of androgens and estradiol in the follicle. (A-B) Production of (A) androgens and (B) estradiol. Only part of the domain
is shown, i.e. theca (white), granulosa cells (dark grey), and a part of the COC (light grey). (C-D) Concentration profiles of (C) androgens and
(D) estradiol. The five time points are equally spaced at 0 (black), 1 (cyan), 2 (blue), 3 (green), 4 (yellow), and 5 days (red) curves. All panels show the
concentration profiles on a scaled domain. The shading indicates the different parts of the follicle, i.e. theca (white), granulosa cells (dark grey),
COC (light grey), and follicular fluid (blue). Androgens are produced only in the theca, and estradiol is produced only in the granulosa cells. In the
follicular fluid steroids are neither produced nor degraded. (E-F) The average steroid concentrations of (E) androgens and (F) estradiol in the
follicular fluid over time. The shaded area indicates the standard deviation of the simulations when noise is applied to the parameter values.
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Figure 6 The emergence of FSH-, LH-, and estrogen receptor gradients in the follicle. (A-C) Receptor profiles of (A) FSH-receptor, (B)
LH-receptor, (C) estrogen receptor. At time zero the receptor concentrations are low and the receptors are distributed homogenously in the follicle
(black line). Over the next five days localised feedbacks create a graded distribution of the receptors. (D-F) Receptor production. (G-I) Unbound
receptors (J-L) Bound receptors (M-O) Receptor activity. The five time points are equally spaced at 0 (black), 1 (cyan), 2 (blue), 3 (green), 4 (yellow),
and 5 days (red) curves. All panels show the concentration profiles on a scaled domain. For better readability we only show the subset of the
domain that includes the theca (white area), granulosa (dark shade), COC (light shade), and part of the follicular fluid (blue shade) on the right hand









+R (ci) . (5)
The reaction terms R(ci) of the components describe
the regulatory interactions based on information from the
literature. We consider four classes of reactions: produc-
tion, decay, complex formation, and catalytic processing
as is discussed in detail below along with an introduction
of all parameter names. The final set of equations for the
reaction termsR(ci) are:
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catalytic production
(9)
R(Rf ) = ρRf (ϑ + σI(1 + σE))︸ ︷︷ ︸
production





R(Rl) = ρRlσI(1 + σE)︸ ︷︷ ︸
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R(Re) = ρRe(1 + σE)(1 − σI1)︸ ︷︷ ︸
production

























We use zero flux boundary conditions for all hormones, receptors and their complexes, i.e.
∇ci = 0. (17)
As initial conditions we use zero for the hormones, receptors and hormone-receptor complexes, because we intend
to study the mechanisms that result in the emergence of the characteristic gene expression patterns in the follicle, i.e.
F(0) = L(0) = E(0) = A(0) = 0
RF(0) = RL(0) = RE(0) = 0
CF(0) = CL(0) = CE(0) = 0. (18)
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The only exception is the initial concentration of the
IGF-receptor complex. IGF-2 and the IGF type receptor
are expressed in the theca already at the time of antrum
formation [60], and the early presence of the IGF-receptor
complex in the theca is important in the model to repro-
duce the experimentally observed early expression of LH
receptors in the theca [15,16]. To reproduce the measured
LH receptor production rate in the follicle at day 0 as
reproduced in Figure 3A we require
I(0) = 0.3KI. (19)
where indicates the restriction to the theca and KI is the
Hill constant for IGF-dependent regulatory processes.
Detailed derivation of the reaction terms
In the following we discuss how the reaction terms in
Eqs. 6-16 were derived from the results reported in the
literature.
Exchange with the blood FSH, LH, and steroid precur-
sors are all produced outside the ovary and reach the theca
via the blood, while estradiol is produced within the ovary
and diffuses out off the ovary into the blood circulation
[12]. The exchange with the blood results in a concen-
tration flux in the theca. We describe this by including a
constant source term for FSH, LH, and the androgen pre-
cursor in the theca, as well as a linear loss term for all
soluble components (i.e. FSH, LH, androgens and estra-
diol) also in the theca. The exchange with the blood occurs
at a rate. Accordingly, the FSH, LH, and androgen deliv-
ery rates, ρF , ρL, and ρA are multiplied by  (Eq. 3), i.e
we have ρF, ρL, and ρA in Eqs. 6-8. The deliv-
ery from the blood is balanced by a removal rate ci,
that applies to all soluble components, i.e. ci = {F , L,E,A}.
Decay, internalization and recycling In the absence
of contrary data we use the simplest model for decay,
linear decay at rate δici, where δi refers to the linear
decay rate constant for component i. Internalized FSH
and LH receptors do not recycle to the cell surface [42].
Potential recycling of estrogen receptors can be absorbed
in the estradiol production rate, in particular because
estrogen receptor signalling enhances estrogen recep-
tor expression. To keep the model simple we thus do
not include an independent term for estrogen receptor
recycling.
Binding reactions FSH, LH, and Estradiol all bind their
respective receptors at rate kon and unbind with a specific
rate kioff , where i = {F , L,E}.
Regulatory interactions The regulatory network is com-
plex with many incoherent feedbacks and indirect reg-
ulatory interactions. Thus, production of FSH, LH and
estrogen receptor are all enhanced by FSH, LH, and estra-
diol signalling [61-64]. However, many of these effects will
reflect the multiple feedbacks between these components
rather than direct auto-activation. These regulatory inter-
actions can be at least in part be entangled with the help
of mutant phenotypes and cell culture experiments. Thus,
if expression of a gene is still observed in a certain mutant,
then it is clear that this factor is not strictly necessary for
the expression of the gene, but just enhances its expres-
sion. In that case the rate is proportional to 1 + f (ci),
where f (·) denotes the particular functional relationship
of the regulation and the+1 term enables the independent
regulation of gene expression by other factors. Likewise
if expression of a gene is observed only with a long delay
after exposure to a certain factor it is likely that this factor
does not act directly, but first up-regulates other factors
that drive expression of the gene of interest. Such delays
are important and need to be incorporated by introducing
the intermediary factor.
Some of the processes are modulated by other signalling
components and we use Hill functions to describe such
regulatory influences. To describe activating influences of






and we use 1 − σi to describe inhibitory impacts of ci.
Here ci denotes the concentration of component i.Ki is the
Hill constant which specifies the concentration of ci where
half-maximal activity is observed, and the Hill coefficient
ni defines the steepness of the response.
In the following we will discuss the reported evi-
dence and how this was translated into the production
terms.
FSH AND LH SIGNALING: Both the LH- and FSH-
receptors are rhodopsin-like G-protein coupled receptors
with great sequence identity [65] and connect to the same
signalling machinery [66-69]. It is therefore possible that
the observed differences in signalling outcomes mainly
reflect ligand availability rather than distinct signalling
programs by the receptor. We follow and test this pos-
sibility by making all regulatory impacts that have been
reported for either LH or FSH signalling depended on
both, i.e. instead of writing either σF or σL we will always
write σG = σF + σL.
IGF SIGNALING: The regulation of IGF signalling
is complex with several ligands, receptors, and mod-
ulating binding proteins and proteases being part of
the regulatory network. In follicles only expression
of IGF-2 but not that of IGF-1 is detected, and expres-
sion of IGF-2 is restricted to the theca [60,70]. The level of
IGF-2 expression seems not to change much during fol-






















Table 1 Parameter values
Parameter Simulation value Reference value References
(0) 5 mm 4-5 mm [20]
v 2.3 × 10−5 mm s−1 ∼10 mm in 5 days [20]
DH 6.7 × 10−5 mm 2 s−1 Average 6.7 × 10−5 mm 2 s−1 for FSH [21,22]
DS 10−4 mm 2 s−1 Small molecule Diff coeff 10−4 mm 2 s−1 [23,24]
DCL 2 × 10−8 mm 2 s−1 1.9 ± 1 × 10−8 mm 2 s−1 [25]
DR 10−7 mm 2 s−1 10−9 − 5 × 10−7 mm 2 s−1 [26-29]
DI 4 × 10−9 mm 2 s−1 IGF receptor complex almost immobile [26]
kon 10−3 nM−1s−1 Standard value [30]
kFoff 5 × 10−4 s−1 Average: KD = 5 × 10−10M−1 [31-36]
kLoff 10
−2 s−1 KD = 9 nM [37]
Parameter values kEoff 10
−4 s−1 KD = 0.1 nM [38]
directly from δF 10−5 s−1 Half-life of FSH in ovariectomized ewes is 20 h [39]
the literature δL 5 × 10−4 s−1 Half-life of LH in ovariectomized rats is 23 minutes [40]
δRF = δRL 3 × 10−5 s−1 Measured decay rate 3 × 10−5 s−1 [41]
δCL 7.5 × 10−4 s−1 Half-life LH/hCG-bound receptor 17 min [40-42],
δCF = δCE = δE = δA 6.4 × 10−5 s−1 Half-life is about 3 hours [39,43-46]
δI 1.2 × 10−6 s−1 Half-life ∼ 10 hours [47-49]
ρRF = ρRL 500 × 0.5 pM s−1 21 receptors/cell/min = 500 × 0.5 pM s−1 [7,41,50-52]
ρE 0.06 s−1 kcat = 0.06 s−1 [53,54]
KM 44 nM KM = 44 nM [53,54]
ρF 2 nM FSH concentration ∼ 2 nM, flux  = 1 s−1 [55]
ρL 0.4 ρF LH concentration 40% of that of FSH [56]
Adapted
ρRE 1.25 pM s
−1 45000 estrogen receptors are detected per cell [57]
ρI 2.8 KIδI Reproduce measured granulosa LH receptor numbers (≤ 3 nM) [7]
ρA 100 nM Reproduce androgen concentration in follicular fluid [55,58]






















Table 1 Parameter values(Continued)
Figure 3
KL 500 × 10 pM Reproduce steepness of expression kinetics in Figure 3A Figure 3A
KF 500 × 3 nM Reproduce steepness of expression kinetics in Figure 3B Figure 3B
KE 35 nM Reproduce steepness of expression kinetics in Figure 3B Figure 3B
ϑ 0.2 Reproduce ordinate intercept in Figure 3C Figure 3C
I(0) 0.3KI Reproduce ordinate intercept in Figure 3A Figure 3A
The table summarizes all parameter values used in the model along with the evidence. For details see the Parameter Section. In addition to the listed parameters we used F(0) = L(0) = E(0) = A(0) = Ri(0) = Ci(0) = 0 as
initial conditions,  = 1 s−1 as exchange rate with the blood, and n = 2 as Hill coefficient. It should be noted that the factor 500 for the FSH and LH receptor production rates and Hill constants reflects the smaller membrane
compartment (∼ 2.5 μm3) compared to the entire cell (1140 μm3 [59]).
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is detected in both granulosa and theca cells of pre-
antral and antral follicles, but expression is stronger in
granulosa compared to the theca [60]. The circulating
IGF concentration in healthy adults is ∼100 nM and the
IGF type I receptor on most cells is typically approach-
ing saturation at a concentrations of 5 nM or lower
[71]. It has therefore been suggested that IGF activity is
mainly regulated through IGF binding proteins (IGFBP),
which sequester IGF in inactive complexes rather than
through differences in the secretion of IGF. The IGFBP4
mRNA is selectively expressed by LH receptor (LHR)
mRNA positive theca interna cells of healthy antral fol-
licles (defined by aromatase and gonadotropin receptor
expression) and by LHR expressing granulosa cells, which
are present in large preovulatory and ovulatory follicles
only (as defined by size and aromatase expression) [70].
In the mouse and the rat FSH stimulates the expression
of PAPP-A, a metalloprotease which degrades IGF-B4
[72]. However, no such an effect was observed in bovine
follicles [73]. The PAPP-A mRNA is abundant in granu-
losa cells of most ovarian follicles without obvious rela-
tion to IGFBP4 expression [70]. IGFBP4 mRNA levels
are markedly increased after treatment with the LH ana-
log, human chorionic gonadotropin (hCG), whereas the
expression levels of IGF-2 and PAPP-A are not signifi-
cantly altered [70]. In summary, there is evidence only for
IGFBP4 being (positively) regulated by LH, while all other
components appear to be expressed at a constant level.
Since IGF-2 is expressed only in the theca, IGF signalling
in the granulosa must be the result of diffusion. The diffu-
sion coefficient of IGF-1 in cartilage has been established
as D = 2.6 × 10−5 mm2 s−1. The diffusion length is
determined also by the rate of ligand removal, by either
receptor binding or unspecific degradation; the half-life of
circulating unbound IGF has been found to be less than
2 min [74]. The characteristic length of such a gradient
would be very short, i.e λ =
√
D
k ≤ 70μm. The IGF bind-
ing proteins protect IGF from receptor binding and can
thereby help to shuttle IGF into the follicle. The half-life
in the presence of IGF binding proteins is increased some
100-fold by IGF binding proteins to several hundredsmin-
utes, and as a result the gradient will some 10-fold wider.
Thus, even though IGF binding proteins sequester IGF
and remove it from the available active pool they also
enable its transport into the follicle. Instead of simulat-
ing all those aspects in detail, we simplify the regulatory
interactions in that we follow only the concentration of the
active IGF-receptor complex which we denote be I.
Production and catalytic conversions IGF RECEPTOR
COMPLEX PRODUCTION: The concentration of the
active IGF complex is enhanced by FSH and LH signalling
[60,72,75], and accordingly we write for the rate of its
generation ρIσG in Eq. 16. Estradiol has been shown to
both enhance and decrease IGF-1 expression in different
experimental systems [76,77] and its effects will therefore
not be included here.
LH RECEPTOR PRODUCTION: FSH and LH sig-
nalling results in the expression of a protein that limits
the half-life of their mRNAs [78-80], such that FSH and
LH receptors can only transiently (i.e. for a few hours)
up-regulate their expression [63,64]. Thus, LH-dependent
induction of increased LH receptor density is present after
2 h, but vanishes after 6h [81]. We will ignore this brief
spike of auto-regulation and assume that there is no direct
auto-regulation of FSH and LH receptor on their own
expression on the relevant time scale (i.e. days). FSH-
dependent LH receptor expression is enhanced by estra-
diol signalling, and LH receptor expression is reduced
(but not absent) in response to the FSH analog in estro-
gen receptor-null follicles [82]. The rate of LH receptor
expression must thus be proportional to (1 + σE). FSH-
dependent LH receptor expression cannot be triggered by
estradiol in the absence of FSH [16,63] and the expression
rate must therefore directly be dependent on an FSH-
dependent term. FSH-dependent LH receptor expression
is delayed [7,15,16]. Thus, stimulation with FSH increased
the LH receptor density 10-fold within two days, with little
change observed after 1 day [7]. FSH thus appears to act
indirectly, possibly via IGF (I) or prolactin signalling [81].
IGF signalling is included explicitly in the model and any
possible effects of other signalling systems such as pro-
lactin can be considered to be implicitly represented by
this variable. The delayed impact of FSH-dependent sig-
nalling of LH receptor expression can then be captured by
making the LH receptor expression rate proportional to
σI(1 + σE). FSH-dependent IGF-1 and LH receptor pro-
duction is inhibited in cumulus cells by factors secreted
by the oocyte [83,84] and LH receptor expression has
been reported to be virtually absent in cumulus cells [83].
However, more recent experiments that use more sensi-
tive techniques revealed the expression of the LH receptor
in cumulus cells [19,85]. We therefore permit LH recep-
tor expression throughout the follicle. In summary, we
have ρRlσI(1 + σE) for the LH receptor production rate in
Eq. 11.
FSH RECEPTOR PRODUCTION: As discussed above,
FSH and LH signalling results in the expression of a pro-
tein that limits the half-life of their mRNAs [78-80], such
that FSH and LH receptors can only transiently (i.e. for
a few hours) up-regulate their expression [63,64]. Also
in case of FSH receptor we will ignore this brief spike
of auto-regulation and assume that there is no direct
auto-regulation of FSH and LH receptor on their own
expression on the relevant time scale (i.e. days). Similar
as for the LH receptor IGF signalling has been shown to
prolong the half-lifes of the FSH receptor mRNAs [72,86].
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The IGF effect is observed only after a delay, i.e. IGF has
been described to enhance FSH-dependent FSH recep-
tor expression on rat granulosa cells after about 3 days of
exposure [72] as is consistent with its delayed induction in
granulosa cells. Also much as in case of the LH receptor,
estradiol enhances FSH receptor expression on rat gran-
ulosa cells [87]. Thus, similar as for the LH receptor, the
rate of FSH receptor expression should be ρRf σI(1 + σE).
Unlike for the LH receptor, FSH-dependent FSH recep-
tor expression is strongly reduced in IGF-null granulosa
cells, but not absent [88], and FSH receptor expression
in response to FSH or LH analogs was not impaired in
estrogen receptor-null follicles [82]. There must there-
fore also be a FSH/LH/estrogen-independent regulation
of FSH receptor expression, possibly triggered by testos-
terone signalling which has been described to induce the
expression of FSH receptor and of aromatase [89]. The
testosterone receptor is restricted to granulosa cells [90]
and given the high steroid concentrations within the fol-
licle the ligand-receptor complex can be assumed to have
a constant activity ϑ . Here we ignore any possible feed-
back signalling that may up-regulate the expression of
the receptor. In summary, we write for the FSH receptor
expression rate ρRf (ϑ + σI(1 + σE)) in Eq. 10.
ESTROGEN RECEPTOR PRODUCTION: In the
mouse estrogen receptor beta is the main form expressed
in the follicles and is found mainly in granulosa cells, but
has also been detected in the theca [82,91]. In bovine and
sheep follicles both estrogen receptor alpha and beta are
expressed in the granulosa and to a lesser extent in the
theca [92,93]. In humans mainly estrogen receptor beta
is detected in the granulosa cells, but also low levels of
estrogen receptor alpha expression has been detected
[94]. Estrogen receptor beta expression is enhanced by
estradiol signalling and the production rate should there-
fore be proportional to (1 + σE) [61,95]. There are also
reports that FSH signalling inhibits estrogen receptor
beta expression [61,95]. Since estrogen receptor beta is
expressed mainly in granulosa cells FSH signalling may
act indirectly via IGF signalling which is prominent in the
theca; IGF receptor signalling has been shown to reduce
estrogen receptor beta expression [96]. Accordingly, the
estrogen receptor expression rate needs to be extended to
(1 + σE)(1 − σI) to include this inhibitory effect. While
LH-dependent signalling appears to interfere with IGF
activity by inducing the expression of IGFBP4 mRNA
[70] this additional feedback will be ignored to keep
the model as simple as possible. In summary, we have
ρRe(1+ σE)(1− σI1) for the estrogen receptor production
rate in Eq. 12.
ANDROGEN PRODUCTION: LH receptor signalling
enhances the production of androgens in the theca [15],
but only 25-50% of androgens is produced in the ovary
(varying through the menstrual cycle) [53]. We therefore
write for the androgen production term ρA(1 + σG) in
Eq. 8. It should be noted that despite the inclusion of FSH
signalling, FSHwill impact very little on androgen produc-
tion because of the very low abundance of FSH receptors
in the theca. It should be noted that high concentrations
of LH appear to inhibit androgen production [97], but we
ignore this to keep the model as simple as possible while
reproducing the data.
ESTRADIOL PRODUCTION: Aromatase converts
androgens into estradiol [98]. No feedback activity involv-
ing aromatase has been reported. To keep the model as
simple as possible we therefore do not explicitly include
the aromatase in the model, but rather incorporate the
regulatory links that impact on its activity. Both the
expression and the activity of aromatase are enhanced by
FSH and LH signalling in the granulosa cells [7,98,99].
Estrogen receptor signalling enhances FSH-dependent
expression of aromatase [82], and IGF signalling is neces-
sary for FSH-dependent expression of aromatase [88,100]
and enhances FSH-dependent estradiol production [101].
Testosterone signalling has been described to induce the
expression of FSH receptor and of aromatase [89]. There
is thus also some FSH/IGF-independent expression of
aromatase. However, since based on data (Figure 3D)
the effect is small we ignore this contribution and take
the aromatase expression rate to be proportional to
I(1 + σEσG). The activity of the aromatase is enhanced
by FSH and should therefore be proportional to I(1 +
σEσG)(1 + σG). Accordingly, we then have according
to the Michaelis-Menten law for the estradiol produc-
tion rate in Eq. 9, ρE AA+KM I(1 + σEσG)(1 + σG), where
KM is the Michaelis-Menten constant;  indicates the
restriction of the aromatase to granulosa and cumulus
cells [102]. FSH and LH-dependent responses have been
shown to be concentration-dependent: low concentra-
tions of FSH and LH act stimulatory while high concen-
trations have negative impact on steroid production [97].
To keep the model as simple as possible while repro-
ducing the data we will not include this feedback here;
it would likely increase robustness to parameter value
changes.
Parameters
In spite of the large number of parameters, the model is
rather tightly constrained because an enormous amount
of data from cows and other animals is available that deter-
mine the parameter values. Where possible we use the
measurements from cows. Table 1 summarizes all param-
eter values used in the model along with the evidence. The
first 28 parameter values have been directly measured in
experiments, 4 further values can be directly inferred from
information in the literature, and the remaining 4 were
set to fit the data in Figure 3, as was the initial condition
I(0). In addition to the parameters listed above we used
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F(0) = L(0) = E(0) = A(0) = Ri(0) = Ci(0) = 0 as
initial conditions to study the emergence of pattern from
zero initial conditions. Furthermore, the exchange with
the blood is modelled by a constant exchange rate, . The
exchange rate with the blood is not known, but as long
as  ≥ 1 s−1 the flux does not impact on the predicted
expression patterns in the follicle; we use  = 1 s−1.
Finally the Hill coefficient in the regulatory terms was set
to n = 2 throughout as in our previous models of devel-
opmental signalling networks [103-105]. In the following
we discuss the literature on the parameter values in detail.
Length and time scales
In both humans and cattle 2-3 waves of follicle maturation
occur until the dominant follicle survives and becomes
ovulated [20,106]. We simulate the first wave of bovine
folliculogenesis and focus on the FSH-dependent develop-
mental phase of the dominant follicle, which lasts about
4-6 days before the dominant follicle of the first wave
undergoes atresia [20]. The final day of the first wave is
already characterized by atresia of the dominant follicle
[16], and accordingly we include only the gene expression
data of the first four days in Figure 3. The follicle is initially
5mm in diameter and expands over 4-6 days to 15-20 mm
[20]. Based on the experimental observation that the folli-
cle grows by about 10 mm in 5 days we use L(0) = 5mm
and v = 2.3 × 10−5 mm s−1.
Diffusion coefficients
The diffusion constant of FSH has been determined as
6 × 10−5 mm2 s−1 for sheep FSH [21] and 7.43 × 10−5
mm2 s−1 for porcine FSH [22]. Accordingly, we will use
the average of 6.7 × 10−5 mm2 s−1 as FSH diffusion coef-
ficient. Given the great similarity of FSH and LH the same
diffusion coefficient will also be used for LH. Steroids are
very small and their diffusion coefficient is therefore set to
DS = 10−4 mm2 s−1, a typical value for small, diffusable
compounds in aqueous solutions [23,24]. The diffusion
coefficient of the LH-bound receptor complex has been
established as 1.9±1.0×10−8 mm2 s−1 [25]. Interestingly,
the diffusion coefficient of hCG-bound receptor complex
was less than 10−9 mm2 s−1. Deglycosylated hCG-bound
receptor complexes had a similar diffusion coefficient as
LH-bound receptor complexes and were internalized also
at the 50-times faster rate that is characteristic for LH-
bound receptors. Accordingly. we have DCL = 2 × 10−8
mm2 s−1, which is more than 1000-fold lower than the dif-
fusion coefficient for the ligand. The diffusion coefficient
of the insulin receptors has been established as (3 − 5) ×
10−8 mm2 s−1 at 23 degree Celsius [26]. Increasing the
temperature to 37 degrees Celsius resulted in rapid recep-
tor immobilization; the immobilization was attributed to
aggregation of hormone-receptor complexes, their inter-
nalization, or a combination of both processes [26]. For
simplicity we did not consider the unbound and bound
IGF receptors separately in the model. To account for this
we do not set the diffusion coefficient for the IGF receptor
complex to zero, but to a 10-fold lower value than mea-
sured at 23 degree Celsius, i.e. DI = 4 × 10−9 mm2 s−1.
The diffusion coefficient of the FSH receptor has been
measured as 4.4 × 10−5 mm2 s−1 [107], which is unusu-
ally similar to that of the soluble protein, but at the upper
end of what has been measured for membrane receptors
[27-29]; the typical diffusion coefficient for unhindered
diffusion in the membrane is about 10−7 mm2 s−1 [27-
29,108]. Since diffusion of the FSH receptors, much as
diffusion of the cytoplasmic estrogen receptors will be
restricted by the cell boundaries, even if cellular diffu-
sion was very fast, we will use DR = 10−7 mm2 s−1, the
diffusion coefficient for unhindered membrane diffusion
[27-29,108], for all other receptors. The use of a con-
tinuum description is reasonable in spite of the spatially
restricted diffusion due to cell boundaries the diffusion
coefficient is sufficiently low such that the cell-restricted
proteins diffuse less than a cell diameter (∼ 7 − 10μm)
within their half-life as discussed in detail before [104].
Binding rates
To avoid numerical problems we formulated our model
for nanomolar concentrations rather than the SI stan-
dard of molar concentrations. The on-rates kon are then
10−3 nM−1s−1 [30]. The affinity constants for the ligand-
receptor interactions have been independently deter-
mined in a range of different species and tissues and the
reported values are very similar. The affinity constant
for the FSH-receptor interaction has been determined as
Ka = 1.5±0.3×109M−1 (Kd = 6.7×10−10M−1) [31] and
Kd = 9.8 × 10−11M−1 [32] in bull testes, as Kd = 6.7 ×
10−10M−1 in rat testes [33], and Kd = 9.4 × 10−10M−1
[34], Ka = 3× 109 M−1 (Kd = 3.4× 10−10M−1) [35], and
Kd = 1.5 × 10−10M−1 [36] for the human FSH receptor.
The average measured Kd = 5 × 10−10M−1 corresponds
to an off-rate kFoff = 5 × 10−4 s−1. Human LH binds the
rat LH receptor with KD = 0.09 nM and the human LH
receptor with a 100-fold lower affinity, KD = 9 nM [37].
hCG binds the human LH receptor with a similar affinity,
i.e. KD = 4 nM [37]. Accordingly, we use kLoff = 10−2 s−1.
Estradiol binds its receptor with KD ∼ 0.1 nM [38] which
corresponds to kEoff = 10−4 s−1. It should be noted that
affinities and half-lifes have been reported to vary due to
different glycosylations [56], but such details are beyond
the scope of this study.
Decay and removal rates
The half-life of LH has been determined in ovary-intact
rats as 13.7±0.7min [40]. The half-life increases to 23.1±
2.9 min in ovariectomized rats [40]. While the degrada-
tion of LH in the ovariectomized rats will also reflect
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receptor-dependent degradation in other organs, 23
min must represent the lower limit for the receptor-
independent half-life for LH (i.e. δL ≤ 5 × 10−4 s−1).
The half-life of LH in ovary-intact rats of 14 minutes
(δCL = 8 × 10−4 s−1) is similar to the measured half-
life of the hCG-stimulated human LH receptor of 17 min
[42], and corresponds well to the decay rate of LH-bound
LHR in MA-10 strains, a clonal strain of mouse Leydig
tumour cells, which is 7 × 10−4 s−1 [41]. In summary we
will use the average rate δCL = 7.5 × 10−4 s−1 for the
receptor-dependent rate of LH clearance. The turnover
rate for unbound LH receptor has been determined as
δRL = 3× 10−5 s−1, and the intracellular degradation rate
is 9 × 10−5 s−1 [41].
The half-life of FSH is about 3h in ovary-intact ewes and
about 20 hours in ovariectomized ewes [39]. While the
degradation of FSH in the ovariectomized ewes will also
reflect receptor-dependent degradation in other organs,
20 hours represents the lower limit for the receptor-
independent half-life for FSH, and we use δF ∼ 10−5
s−1. The receptor-dependent half-life of 3h corresponds to
δCf = 6.4× 10−5 s−1. Given the great similarity of the LH
and the FSH receptor we use the same ligand-independent
turnover rate, i.e. δRF = δRL = 3 × 10−5 s−1.
The half-life of androgens and estradiol has been
reported as 2-3 h [43-45]. The half-life of the estrogen
receptor-alpha protein has been reported as 3 h in the
absence of estrogen, and as 1h upon addition of the hor-
mone [46]. ERa half-life subsequently increases over time,
achieving a half-life of ∼6 h in 72 h of estrogen treatment
[46]. In summary we use, similar as for the FSH receptor
complex, 3h as half-life for the steroid components, i.e.
δA = δE = δRE = δCE = δCF = 6.4 × 10−5 s−1.
The half-life of overexpressed IGF receptor complexes
has been measured to be much larger than 6 hours and
smaller than 16 hours [47], which would correspond to a
decay rate of about 2 × 10−5 s−1. In a subsequent study
the same group reported a decay rate of 8 × 10−5 s−1
using cells that expressed 105−106 receptors per cell [48].
Granulosa cells have been reported to express 1125± 382
receptors per cell [109]. The rate of internalization was
further reported to slow down substantially as insulin
receptors become saturated, and half-maximal inhibition
was observed already at 0.1 nM insulin concentrations;
addition of 100 nM insulin reduced the internalization
rate to less than 10% [48,49]. Based on these in vitro data
the IGF receptor turnover rate in granulosa cells is diffi-
cult to estimate, but it is likely to be substantially lower
than the measured 2 − 8 × 10−5 s−1, and we will use
δI = 1.2 × 10−6 s−1.
Finally, the flux rate  determines the rate at which the
soluble factors are delivered and removed from the folli-
cle. This rate is not known. A low flux rate can lead to
the removal and depletion of those soluble factors, which
are delivered to the theca, i.e. FSH, LH, and the steroid
precursor. A higher flux rate can in principle always
be balanced by a higher production rate, but can cause
numerical problems. To avoid such artefacts and problems
we use as flux rate  = 1 s−1.
Production rates
The bovine serum FSH concentration during the follicu-
lar phase has been established as 66 ng/ml in one study
[110] and as ∼ 20 ng/ml in several others [55,111-113].
If we use 1g ∼ 1 ml as done in similar studies before
[114] and use 30 kDa as the molecular weight of FSH we
arrive at a serum concentration of 0.7-2 nM for FSH. We
note that the reported bovine FSH concentration is some-
what lower than the reported concentration in humans.
Human FSH and LH concentrations are typically reported
as IU/l which can be converted into molar concentrations
based on reported conversions into protein weight per
liter. Thus, dependent on the hormone standard used 1
IU corresponds to about 46 μg FSH or about 23 μg LH
[115]. Themolecular weight of both proteins is 30-35 kDa,
depending on glycosylation. 1 IU/l FSH then translates
into about 1.5 nM, and 1 IU/l LH translates into about 0.75
nM. FSH levels are high during the menstruation period
(midcycle phase 4.5-22.5 IU/L) and lower in the middle
of the cycle (follicular phase 3.9-8.8 IU/L and luteal phase
1.8-5.1 IU/L) [116,117]. In the human follicular phase the
average FSH serum concentration has been reported as
5.3 IU/liter (8 nM) and the average LH concentration as
4.2 IU/liter (3.15 nM) [56]. In humans the serum LH con-
centration is thus about 40% that of FSH. The bovine
LH concentration was determined as 0.63 ng/ml per liter
(and thus 20 pM) [55]. The low reported LH concentra-
tion in the bovine study may reflect the short half-life
of only 14 min [40] which makes accurate measurements
of the LH concentration more difficult. In fact, in ewes
the LH concentration has been reported as 25 ng/ml - 50
ng/ml LH [118] which would be in the expected range.
The reported LH concentration in the bovine follicular
fluid ranges from 0.02 to 0.63 nM [55,58] where the lower
value was again reported by Rhind and co-workers. In
conclusion, we suspect that the reported bovine LH serum
concentration is underestimated. We therefore adjusted
the production and loss rate in the theca such that the FSH
concentration was 2 nM, the upper range of the reported
bovine concentrations and the lower range of the reported
human concentrations, i.e. ρF = 2 nM, and the LH con-
centration to 40% of this, i.e. ρL = 0.4ρF . Oscillations in
the dynamics of LH are ignored in this model. The impact
of the LH/FSH concentration and ratio are explored in
detail in the Results section.
The LH receptor production rate has been measured
in a cell culture system as 21 receptors/cell/min [41] and
the cell volume of human ovarian granulosa cells has been
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established as 1140 μm3 [59]. This would then translate
to ρRL = 0.5 pM s−1. The LH and FSH receptors are
plasma membrane receptors and their reaction volume is
therefore much smaller, even though both the oocyte and
granulosa cells have elaborate numerous cytoplasmic pro-
jections andmicrovilli that interdigitate with each other to
create an extremely large surface area for diffusion. Thus,
the surface area of granulosa cells has been established
by scanning electron microscope as 198.5 ± 6.3 μm2 in
unstimulated control rabbits and as 242.8 ± 9.28 μm2 in
rabbits injected 12 h earlier with hCG [119]. The effec-
tive binding volume for the receptors would thus be much
smaller, i.e. 250 μm2 × 0.01μm = 2.5 μm3 where we use a
binding length of 10 nm as discussed elsewhere [120]. To
take into account that the LH receptor is a membrane pro-
tein we thus need to use an about 500-fold higher receptor
production rate, i.e. ρRL = 250 pM s−1 for the discrete
receptor reaction volume. We note that while this num-
ber provides a better estimate for the effective binding
kinetics, it greatly over-estimates the total amount of hor-
mone that is removed, since we do not exclude the cell
volumes (that are inaccessible to the hormones) from the
simulations. Since the hormone concentration is kept con-
stant in the theca this, however, does not affect any of our
predictions. To include the effects of the membrane local-
isation of receptors a cell-based model would need to be
devised.
The FSH receptor expression rate was set to that of the
LH receptor, i.e. ρRF = ρRL = 250 pM s−1. The activity
of the FSH/LH-independent regulation of FSH receptor
expression was set to ϑ = 0.2 to reproduce the ordinate
intercept in Figure 3C.
The simulated LH receptor concentration also depends
on the concentration of IGF receptor complexes and thus
on ρI . In cultured rat granulosa cells 200 LH receptor
sites were detected per cell [7] which corresponds to a
concentration of about 300 pM if we use 1140 μm3 as
granulosa cell volume [59] and 150 nM if we use the
much smaller reaction volume of 2.5 μm3 as discussed
above. Stimulation with FSH increased the LH recep-
tor density 10-fold within two days, with little change
observed after 1 day [7]. The maximal LH receptor con-
centration would thus be 3 nM (or 1500 nM if we use the
much smaller reaction volume) in our model. To achieve
such a concentration range in the model we require
ρI = 2.8KIδI .
We have found measurements of the estrogen receptor
concentration only in the pituary of ewes. In cell culture
systems about 45000 estrogen receptors are detected per
cell [57]. This would correspond to about 65 nM and we
therefore use ρRE = 1.25 pM s−1. It should be noted that
the much larger estrogen receptor concentration reflects
its cytoplasmic/nuclear rather than membrane localisa-
tion. This much higher concentration, however, does not
impact the model predictions as long as the Hill constant
KE is adjusted accordingly.
Androgen production depends on the precursor con-
centration and on the stimulating impact of FSH and
LH signalling. The most potent androgen, testosterone,
is secreted by the adrenal zona fasciculata (25%) and
the ovarian stroma (25%), with the remaining 50%
being produced from circulating andostrenedione [53].
Androstenedione is secreted by the adrenal zona fasci-
culata (50%) and the ovarian stroma (50%, but varying
through the menstrual cycle). The maximal follicular fluid
concentrations of androstenoide and testosterone have
been reported as 107 nM and 100 nM respectively [58].
Accordingly, we use as androgen production rate ρA =
 × 100 nM, where 100 nM would be the concentration
of the precursors.
Estradiol is produced from androgens by the
cytochrome P450 enzyme aromatase. The human
cytochrome P450-dependent conversion rate, the rate
limiting step in estrogen production, has been established
as kcat = 0.06 s−1; KM = 44 nM [54]. Accordingly we use
ρE = 0.06 s−1 and KM = 44 nM.
Hill constants and coefficients
The Hill coefficient n is not known, and much as in our
previous studies of developmental signalling processes
[104,105] we will use n = 2 throughout, which is in the
likely physiological range [30] and which has the added
benefit of rendering the simulation numerically more sta-
ble. Hill constants determine the concentration at which
half the activity is attained. There are no direct measure-
ments of the Hill constants, but these must lie within
the dynamic range of the receptor-ligand complex con-
centration to enable the reported regulatory effect of the
regulatory components. The Hill constant for the LH
receptor determines the slope of the LH expression kinet-
ics in Figure 3A and, to reproduce the data, needed to be
set to KL = 500 × 10 pM where the factor 500 reflects
the smaller reaction volume of the membrane receptors
as discussed in the previous section. This would corre-
spond to about 10 active ligand-receptor complexes for
half maximal activation. This number for the LH receptor
is rather low. However, as discussed above the concen-
trations in the model are about 4-fold lower than in
reality because we do not explicitly consider the restric-
tion to the membrane. Moreover, receptors cluster on
the membrane and thus increase their local concentra-
tion. The Hill constants of the FSH and estrogen receptors
determine the slope of the LH expression kinetics in
Figure 3B and needed to be set to KF = 500 × 3 nM
and KE = 35 nM to reproduce the data. Also in case
of the estrogen receptor the real cellular concentration
will be higher because estrogen receptors move to the
nucleus which has a smaller volume of about 250 μm3
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[59]. There is thus a further concentration by compart-
mentalization. While the IGF receptor concentration is
low (1.7 nM IGF receptors [109]), the IGF receptor com-
plex is used to approximate the activity of the aromatase
which likely has a much higher concentration, given its
cytoplasmic/nuclear localisation. We require KI = 5 μM
to obtain a final estradiol concentration of 200-250 nM
in the follicular fluid. The value of KI only affects the
rate of estradiol production, but none of the other kinet-
ics as long as I(0) = 0.3KI , and ρI = 3KIδI are adapted
accordingly.
Numerical solution
The PDEs were solved with finite difference meth-
ods (pdepe) as implemented in MATLAB. The robust-
ness of the model to small parameter variations was
assessed by simultaneously adding Gaussian noise to
all parameter values. To this end 100 simulations were
run with parameter values drawn from a Gaussian dis-
tribution with mean values equal to those in Table 1
and with standard deviation 0.2 and the standard devi-
ation in model output was calculated and included as
shaded area in all figures where it does not reduce
readability.
Results and discussion
Model consistency with data
In summary, the model consists of 11 variables and 36
independent parameters in addition to the initial condi-
tions, zero flux boundary conditions, the flux term ,
and the general Hill coefficient n (Table 1). In spite of
the large number of parameters, the model is very much
constrained by experimental data. Thus, for more than
three quarters (28) of these 36 parameters the values were
set according to reported measurements (Table 1). These
represent the measured affinities of the ligand-receptor
interactions, the protein half-lifes, production rates, as
well as the growth rate of the follicle. All initial con-
ditions except for that of the IGF signalling complex,
I(0), were set to zero because we wanted the patterns
to emerge from the regulatory interactions rather than
being pre-set. I(0) was set as to reproduce the ordinate
intercept in the LH expression kinetics in Figure 3A. The
production rates that had not been directly measured
as well as the response threshold of IGF signalling (Hill
constant KI ) were set as to match the reported concen-
trations. All other response thresholds (Hill constants)
could be inferred from the measured gene expression
time courses (Figure 3). We set the response thresholds
for LH signalling (Hill constant KL) as to reproduce the
slope in the time course of LH-receptor expression in
the theca (Figure 3A) and the response thresholds for
FSH and estrogen signalling (Hill constants KF , and KE)
to reproduce the slope of the LH expression kinetics in
the granulosa (Figure 3B). The activity of the FSH-/LH-
independent expression of FSH receptors, ϑ , was set as
to obtain the ordinate intercept in the measured FSH
receptor expression kinetics (Figure 3C).
The delay in the emergence of the expression of the
LH-receptor and of aromatase activity in the granulosa
(Figure 3B,D) is the result of the slow emergence of IGF-
receptor complexes in the granulosa. The time scale on
which IGF-receptor complexes emerge is determined by
its turnover rate δI = 1.2 × 10−6 s−1. For a shorter
half-life the delay would be shorter, while for a longer
half-life the delay would be even longer. While this rate
has been determined by several research groups, the mea-
surements have all been carried out with cell lines that
overexpressed the IGF receptor at levels more than 100-
fold higher than what has been observed in granulosa cells
[47-49]. Moreover, the turnover rate was found to slow
down as receptors become saturated by ligand [47-49]. As
a result the experimentally determined rates of 2 − 8 ×
10−5 s−1 presumably reflect a maximal possible turnover
rate, rather than a physiological turnover rate. Given the
importance of this rate for the signalling processes in the
follicle this rate should be measured again in the natural
environment.
In spite of these limitations in the determination of δI ,
we note that the measurements, although obtained by
many independent research groups, are largely consis-
tent and also reproduce additional data very well. One
example is provided by the slope in Figure 3C, which
is determined by the rate of FSH receptor expression,
ρRf , a rate that was set to be equal to the measured
value for the LH-receptor [41]. Further aspects are also
reproduced very well (Figures 4, 5 and 6) as discussed
below.
While inaccuracies in the measurements are still possi-
ble, we note that the relative production and decay rates,
the Hill constants, and the binding affinities are interde-
pendent and inaccuracies in the directly measured param-
eter values are therefore largely compensated by the fitted
parameters. As a result, we obtained similar results when
we changed parameter values during the course of model
development as long as we adjusted the 8 parameters dis-
cussed above such that the key characteristics were all still
reproducable. Given the large number of parameters and
studied outputs a global sensitivity analysis of such spatio-
temporal model is impossible, in particular because, for
the analysis to be informative, the 8 parameter values and
the non-zero initial condition I(0) that were not measured
directly would always have to be adjusted such that the
model output would still match the measured concen-
trations (Table 1) and expression kinetics (Figure 3). In
a model of lung development we have previously added
Gaussian noise to all parameter values to study the effect
of simultaneous variations in several parameter values
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[104], and with a similar approach we find that the over-
all model behavior is robust in the presence of moderate
noise levels; shaded areas are included in all Figures where
it does not reduce readability to indicate the standard
deviation in the model output to Gaussian noise with
standard deviation of 20%. Single parameter perturba-
tions can be used to identify critical parameters, and such
perturbations are particularly valuable when compared
to similar experimental perturbations. No bovine trans-
genic data is available and murine folliculogenesis is very
different [1].
Hormone gradients in the follicle
Initially no hormones or receptors (except for IGF-
receptor complexes) are present in our model. LH and
FSH then diffuse into the domain from the boundary. As
shown in Figure 4A,B we observe the formation of a gra-
dient of both FSH and LH. If we plot the gradient on a
domain where the size of the growing domain is scaled
with respect to the current length of the domain L(t), we
notice that the relative extension of the gradients shrinks
as the domain expands (Figure 4C,D).
An important aspect, so far neglected, is the formation
of the antrum, a fluid-filled cavity within the follicle. In
our 1D-model we captured this by including a fluid-filled
part of our domain lacking cells and as such receptor-
free (Figure 2C,D). As a result diffusion is unhindered in
that part of the domain (shaded blue) and the gradients
extend further from the source in the theca to the sink
in the granulosa and cumulus oophorus-oocyte complex
(COC) (shaded grey) (Figure 4E,F). In fact, it is likely that
the concentrations in the follicular fluid are homogenous
since the aqueous fluid [121] will be mixed as the animal
moves.
When we include such rapid mixing in the follicular
fluid then the concentration gradients vanish in this com-
partment and the average concentrations in the follicular
fluid increase (Figure 4G,H).
In both scenarios we predict a difference between the
concentrations in the serum and in the follicular fluid
(Figure 4E-H). The extent of this difference depends on
how much hormone is bound by the receptors, and thus
on the receptor concentration. The receptor concentra-
tion in turn depends on the size of the reaction volume,
which we estimated to be some 500-fold smaller than the
cell volume. For a smaller factor the concentration dif-
ference between follicular fluid and serum would be less
pronounced. The bovine FSH concentrations have been
reported to be similar in the serum (0.7-2 nM) and in
the follicular fluid (0.6-2 nM), but the measured range
is wide and the data were not acquired in the same ani-
mals [55,58,110]. In humans, such concentration differ-
ences between serum and follicular fluid has indeed been
observed [122].
Steroid production in the follicle
Androgens are produced from steroid precursors in the
theca or reach the theca via the capillary blood vessels
surrounding the follicle [53]. Estradiol is produced only in
granulosa [7,98,123]. In the simulation androgen produc-
tion was therefore restricted to the theca, while produc-
tion of estradiol was restricted to granulosa (Figure 5A,B).
The simulation further predicts that within the granu-
losa layer estradiol production is strongest close to the
theca where the positive impact of IGF signalling on aro-
matase expression would be stronger and the androgen
concentration higher (Figure 5B).
From the theca androgens either diffuse into the follicle
or are removed from the follicle via the blood circulation.
Accordingly, the androgen concentration is the highest
in the theca and falls towards the centre of the follicle
(Figure 5C). Similarly, the estradiol concentration is the
highest in the granulosa and falls towards the follicular
fluid and the theca (Figure 5D). Interestingly, within the
follicular fluid the androgen concentration is predicted
to decline (Figure 5E) while the estradiol concentrations
are predicted to rise (Figure 5F) as the follicle becomes
larger. Similarly, the androstenedione concentration was
found to decline from 107 nM to 33 nM and the testos-
terone concentration was found to decline from 100 nM
to 10 nM [58]. In the same experimental study the estra-
diol concentration in the follicular fluid was found to
rise from 17 to 230 nM [58]. While the maximal testos-
terone concentration in the follicular fluid is determined
by the precursor concentration and thus ρA and the max-
imal concentration of estradiol in the follicular fluid is
determined by the activity of the aromatase and thus
by KI , the decreasing testosterone and increasing estra-
diol concentrations themselves are not hard-coded and
emerge from the regulatory interactions. It should be
noted that while estradiol has been reported to down-
regulate testosterone production [82] in the model the
decline in the testosterone concentration in the follicular
fluid is observed without such negative feedback on its
production.
A self-emerging spatial organisation of receptor
distributions
The expression patterns of the FSH- and LH-receptor
in bovine follicles over time have been reported [15,16].
FSH-receptors localize mainly to the granulosa [55] while
LH-receptor are first present close to the theca and
emerge later in the granulosa [15,16] with a declining
gradient in LH-receptor expression towards the center of
the follicle [83,124]. How this distribution emerges is not
clear. The model now reveals that these observed recep-
tor expression patterns result directly from the reported
regulatory interactions. Thus, the model reproduces the
high concentration of FSH-receptors in the granulosa
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cells (Figure 6A) and its much lower expression in the
theca (Figure 5D). LH-receptors on the contrary initially
mainly concentrate in the theca (Figure 6B,E, light blue
line), later also in the granulosa and in the outer part
of the COC (Figure 6B,E, green-red lines). The extent to
which LH-receptors appear in the granulosa depends on
the value of the Hill constant for the FSH-receptor, KF :
the stronger the FSH-receptor signalling in the granulosa,
the wider the LH-receptor distribution in the COC. Note
that in Figure 6 we only show the subset of the domain
that includes the theca, granulosa, COC and part of the
follicular fluid.
Estrogen receptors are expressed in immature granulosa
cells [95], but the expression of estrogen receptor-beta,
the dominant form in the ovary, is mainly restricted to
the granulosa cells of growing follicles [125,126]. Such
a stronger expression in the granulosa emerges in our
model as the result of the negative impact of FSH and LH
signalling (via IGF signalling) on estrogen receptor expres-
sion. The stronger this feedback, the more restricted is
the expression of the estrogen receptor to granulosa and
COC (Figure 6C,F). We note that low expression levels
of estrogen receptor in the theca are important to repro-
duce the physiological gene expression time course of
LH-receptor expression. Some expression of the estrogen
receptors in the theca has indeed been reported [127] and
conditional knock-outs reveal an important role of estro-
gen receptor in the theca and absence of the receptor
results in infertility in mice [126]. The mice are character-
ized by the presence of more antral follicles and failure to
ovulate [126].
The FSH-receptor concentrations nicely demonstrate
the consistency of the reported measurements. Even
though the FSH-receptor expression rate ρRf was set
based on measured values and was thus not adapted to
fit any particular feature of the model, the predicted FSH-
receptor concentrations agree well with earlier measure-
ments. Measurements in isolated granulosa cells reveal
a density of 1500 FSH receptors by the secondary stage
of follicular development and FSH-receptor numbers
remains relatively constant during further development
[50]. Available data in the human indicate that the number
of FSH-receptors does not change during antral devel-
opment, at least not until follicles reach a diameter of
12 mm [4]. Using a granulosa cell volume of 1140 μm3
[59] 1500 FSH-receptors correspond to 2.2 nM (and to
1100 nM if we used the small membrane reaction vol-
ume of 2.5 μm3). This concentration is indeed observed
with a 2-fold increase at later stages in the parietal gran-
ulosa (Figure 6A,D). Such delayed 2-fold increase in FSH-
receptor expression is also observed in experiments [128].
The IGF production rate was adjusted to reproduce the
measured number of LH receptors in isolated rat granu-
losa cells which would correspond to 0.3 nM if we use the
entire cell volume or 150 nM for the smaller membrane
compartment (Figure 6B) [7]. In the in vitro experiments
the LH receptor density increased some 10-fold over 2
days in response to ligand stimulation [7]. A slow 10-fold
increase in LH receptors also emerges from the regu-
latory interactions in the model (Figure 6E). The estro-
gen receptor expression rate was adjusted to obtain the
typical estrogen receptor concentration of about 65 nM
(Figure 6C,F) [57].
While estrogen receptors are saturated at the lig-
and concentrations available in the follicle (Figure 6I,L),
ligand-bound LH-receptors are rapidly internalized, and
the concentration of ligand-bound LH-receptors is there-
fore much lower than the total LH-receptor concentration
(Figure 6H,K). About one quarter of all FSH-receptors
remain unbound (Figure 6G,J). Data from the hamster
indicate that approximately 1% of the FSH serum concen-
tration is tissue-bound within the ovary [129], but these
measurements are difficult to compare to the simulation
results.
It is an open question as to how the signalling responses
of FSH- and LH-receptors differ. The differential activity
in themodel is the consequence of the combined effects of
different spatial gradients, different ligand-receptor affini-
ties and their different Hill constants. The downstream
signalling effects of the active receptors are equivalent.
The activity of FSH signalling is mainly restricted to the
granulosa cells but also extends to the theca (Figure 6M).
LH signalling on the contrary first concentrates in the
theca and then expands to the granulosa (Figure 6N).
Estrogen receptor activity extends throughout the gran-
ulosa and COC, and is somewhat lower in the theca
(Figure 6O).
Conclusion
We have developed a 1D-computational model to inte-
grate the large amount of published data dealing with
bovine ovarian follicle development into a consistent
spatio-temporal framework of ovarian folliculogenesis. A
large amount of quantitative data is available that deter-
mined the parameter values in the constructed model
(Table 1). As a result the model is highly constrained
and reproduces biological observations , which were not
explicitly included in the model and which were previ-
ously difficult to understand by simple verbal reasoning.
The spatio-temporal model reveals the importance of
distances and gradients in the developing follicle. Because
of the receptor-dependent removal of the hormones, their
activity is strongly limited in fields of cells that express
the receptor but not the ligand. Both human and bovine
follicles grow to a similar final size of approximately
20 mm. If the follicles were filled entirely with recep-
tor expressing cells and if the oocyte were located in the
center of the follicle, then the cells close to the oocyte
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would not receive any endocrine signalling (Figure 4C,D).
This limitation is overcome by the emergence of a fluid
filled cavity and the localization of the COC in the
periphery of the follicle (Figure 2C,D). As a result high
concentrations of the exogenous hormones reach the
COC (Figure 4E,F), in particular if we also take rapid mix-
ing of the hormones in the fluid-filled cavity into account
(Figure 4G,H).
In agreement with earlier experimental data the model
predicts that estradiol is produced mainly in the pari-
etal granulosa layer (close to the theca) (Figure 5A,B),
because here the androgen concentration is higher and
the stimulating impact of IGF-receptor complexes, and
FSH- and LH-signalling stronger (Figure 6M-O). More-
over, in agreement with earlier experimental observations
the model predicts that the testosterone concentration
in the follicular fluid declines while the estradiol con-
centration increases as the follicle grows and develops
(Figure 5E,F). Overall, the receptor patterns emerging
in the simulation closely match the observed expression
patterns. This demonstrates that the observed expres-
sion patterns directly result from the reported regulatory
interactions without need for further restrictions. Inter-
estingly, MAPK-signalling has been shown to be required
for the spatial propagation of LH-dependent signalling
[130]. This is in good agreement with the model which
requires IGF-dependent signalling for the emergence of
LH-receptors in the granulosa.
We obtained these consistent results without requiring
different signalling impacts of FSH and LH. Their dif-
ferential impact in the model results entirely from the
different expression patterns of their respective receptors,
protein concentrations, binding affinities, diffusion con-
stants, and signalling thresholds. It has previously been
noticed that their intracellular signalling responses are
virtually identical [65-69]. A similar case of where two
homologous proteins take different roles even though
they connect to the same signalling machinery has been
reported for FGF4 and FGF8 during limb bud develop-
ment. FGF4 and FGF8 have different roles, yet if the
Fgf4 gene is expressed from the Fgf8-regulatory sequence
instead of Fgf8 it can take over the function of FGF8 [131].
It is thus the differential spatio-temporal expression con-
trol rather than the differences on the protein level that
convey the different functions.
With a data-based, validated model at hand it should
now become feasible to investigate the molecular basis
of infertility with a more integrated approach that
reflects the tight coupling between the many regulatory
processes. Most cases of primary ovarian insufficiency
have remained unexplained so far. Future work should also
focus on understanding species-specific differences. The
model was mainly built with data from cattle, whereas all
knock-out data originate from transgenic mouse models.
Murine follicles differ from bovine and human follicles in
rapid maturation and small size with a diameter of only
0.5-0.6 mm at ovulation [1]. Given the small size of the
murine follicles the diffusional gradients must be steeper
to scale with the size of the domain. Here it is interesting
to note that the affinity of human LH has been found to be
about 100-fold higher to rat LH-receptor than to human
LH-receptor [37].
To further apply the model to human ovarian folli-
cle development and infertility it will be important to
establish all key parameters in human follicles as well
and to develop a 3D-model. The diameters as well as
the follicular fluid volume and granulosa cell numbers of
growing human follicles have been reported previously
[13,14] and further measurements can now be made using
the latest imaging technology, such as magnetic reso-
nance imaging (MRI). Moreover, it is now increasingly
feasible to obtain gene expression kinetics from in vivo
and cultured follicles at defined stages and to manipu-
late in vitro cultured follicles. It will then be interesting
to address the detailed impacts of changes in binding,
decay, and production rates as decay rates and binding
affinities are known to vary not only with age but also
during the follicular phase of the menstrual cycle due to
changes in the glycosylic moiety of the hormone [56,132].
In patients undergoing assisted reproduction the feed-
back with the pituitary is voluntarily disrupted. When
active, this feedback leads to changes in the serum levels
of FSH and LH in response to changes in estradiol secre-
tion. To better understand the manifestation of disease
it may become important to also include this feedback
in the model rather than constant concentrations of FSH
and LH.
Data-based, validated computational models of biomed-
ical processes are still rare, but they are likely to become
invaluable tools to define the molecular causes of disease
and to develop novel therapeutic approaches that respect
the complex regulatory logic of biological systems.
Additional file
Additional file 1: Figure S1 Time-dependent expression profiles in
the follicle. This figure is the same as Figure 3, except that the thickness of
the thecal layer is increased by 20%. Simulated and measured expression
levels of LH receptor in granulosa and theca, and of the FSH receptor and
the aromatase in the granulosa during the 1st wave of the bovine follicle
maturation process. The data was recorded by [15,16]. The lower curves
that extend to 10 days are the measurements in [16]; the follicles in these
measurements were growing more slowly than in the study by [15]. Note
that the dominant follicle undergoes atresia from day 6. (A) Data (dotted
lines) and simulation predictions (solid line) of LH receptor expression in
the theca. (B) Data (dotted lines) and simulation predictions (solid line) of
LH receptor expression in the granulosa. (C) Data (dotted lines) and
simulation predictions (solid line) of FSH receptor expression in the
granulosa. (D) Data (dotted lines) and simulation predictions (solid line) of
aromatase expression in the granulosa.
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Additional file 2: Figure S2 FSH and LH gradient formation in the
follicle. This figure is the same as Figure 4, except that the thickness of the
thecal layer is increased by 20%. At time zero no hormones are present in
the follicle (black line). Over the next five days LH and FSH diffuse into the
follicular domain from the boundary (theca) and form a gradient. The five
time points are equally spaced at 0 (black), 1 (cyan), 2 (blue), 3 (green), 4
(yellow), and 5 days (red) curves. Panels A and B show the profiles on the
growing domain. Panels C and D show the concentration profiles on a
scaled domain. Panels E and F show the concentration profiles on a scaled
domain if we include the fluid-filled antrum on one site of the COC block.
Panels G and H show the concentration profiles on a scaled domain if we
assume rapid mixing in the fluid-filled antrum. The shading indicates the
different parts of the follicle, i.e. theca (white), granulosa cells (dark grey),
cumulus cells (light grey), and follicular fluid (blue). Note that the theca and
granulosa layers are very thin and thus barely visible.
Additional file 3: Figure S3 The production of androgens and
estradiol in the follicle. This figure is the same as Figure 5, except that the
thickness of the thecal layer is increased by 20%. (A-B) Production of (A)
androgens and (B) estradiol. Only part of the domain is shown, i.e. theca
(white), granulosa cells (dark grey), and a part of the COC (light grey). (C-D)
Concentration profiles of (C) androgens and (D) estradiol. The five time
points are equally spaced at 0 (black), 1 (cyan), 2 (blue), 3 (green), 4 (yellow),
and 5 days (red) curves. All panels show the concentration profiles on a
scaled domain. The shading indicates the different parts of the follicle, i.e.
theca (white), granulosa cells (dark grey), COC (light grey), and follicular
fluid (blue). Androgens are produced only in the theca, and estradiol is
produced only in the granulosa cells. In the follicular fluid steroids are
neither produced nor degraded. (E-F) The average steroid concentrations
of (E) androgens and (F) estradiol in the follicular fluid over time.
Additional file 4: Figure S4 The emergence of FSH-, LH-, and estrogen
receptor gradients in the follicle. This figure is the same as Figure 6,
except that the thickness of the thecal layer is increased by 20%. (A-C)
Receptor profiles of (A) FSH-receptor, (B) LH-receptor, (C) estrogen
receptor. At time zero the receptor concentrations are low and the
receptors are distributed homogenously in the follicle (black line). Over the
next five days localised feedbacks create a graded distribution of the
receptors. (D-E) Receptor production. (F-H) Unbound receptors (I-K) Bound
receptors (L-N) Receptor activity. The five time points are equally spaced at
0 (black), 1 (cyan), 2 (blue), 3 (green), 4 (yellow), and 5 days (red) curves. All
panels show the concentration profiles on a scaled domain. For better
readability we only show the subset of the domain that includes the theca
(white area), granulosa (dark shade), COC (light shade), and part of the
follicular fluid (blue shade) on the right hand side of the domain.
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